Naseri Erdinc, Yenisehirli Aydan
Department of Cardiovascular Surgery, Faculty of Medicine, Gaziosmanpasa University, Tokat 60100, Turkey.
Eur J Pharmacol. 2006 Feb 15;531(1-3):226-31. doi: 10.1016/j.ejphar.2005.12.025. Epub 2006 Jan 24.
Vasorelaxant effects of H+/K+-ATPase were previously demonstrated in artery rings isolated from experimental animals. We examined the effects of clinically used H+/K+-ATPase inhibitors on isolated human internal mammary (n=19) and radial (n=5) arteries. Omeprazole and lansoprazole (30-300 microM) both induced concentration-dependent, reversible and reproducible relaxations of arteries which were precontracted with phenylephrine (5 microM), histamine (15 microM), high K+ (80 mM), ouabain (1 microM) and K+ free solution. Relaxant responses were similar in both arteries. Presence of Nomega-Nitro-L-arginine methyl ester (30 microM) had no effect on lansoprazole-induced responses, thus relaxations are independent from nitric oxide. Relaxation in the K+ free medium implies that this action could not be due to the inhibition of H+/K+-ATPase. Lansoprazole (300 microM) inhibited Ca2+-induced contractions in high K+-Ca2+ free medium. Omeprazole and lansoprazole may act on a common mechanism which plays a crucial role in regulating human vascular tone and that mechanism appeared to be involved in the regulation of intracellular Ca2+.
H⁺/K⁺-ATP酶的血管舒张作用先前已在从实验动物分离的动脉环中得到证实。我们研究了临床使用的H⁺/K⁺-ATP酶抑制剂对分离的人乳内动脉(n = 19)和桡动脉(n = 5)的作用。奥美拉唑和兰索拉唑(30 - 300微摩尔)均诱导了浓度依赖性、可逆且可重复的动脉舒张,这些动脉预先用去氧肾上腺素(5微摩尔)、组胺(15微摩尔)、高钾(80毫摩尔)、哇巴因(1微摩尔)和无钾溶液进行了预收缩。两条动脉中的舒张反应相似。N⁻硝基-L-精氨酸甲酯(30微摩尔)的存在对兰索拉唑诱导的反应没有影响,因此舒张作用与一氧化氮无关。在无钾培养基中的舒张表明这种作用不可能是由于H⁺/K⁺-ATP酶的抑制。兰索拉唑(300微摩尔)在高钾 - 无钙培养基中抑制了钙诱导的收缩。奥美拉唑和兰索拉唑可能作用于一种共同机制,该机制在调节人体血管张力中起关键作用,并且该机制似乎参与了细胞内钙的调节。